- Home
- FUNC vs CDXS Comparison
FUNC vs CDXS Comparison
Compare FUNC & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUNC
- CDXS
- Stock Information
- Founded
- FUNC 1900
- CDXS 2002
- Country
- FUNC United States
- CDXS United States
- Employees
- FUNC N/A
- CDXS N/A
- Industry
- FUNC Major Banks
- CDXS Major Chemicals
- Sector
- FUNC Finance
- CDXS Industrials
- Exchange
- FUNC Nasdaq
- CDXS Nasdaq
- Market Cap
- FUNC N/A
- CDXS 230.3M
- IPO Year
- FUNC N/A
- CDXS 2010
- Fundamental
- Price
- FUNC $29.69
- CDXS $2.81
- Analyst Decision
- FUNC
- CDXS Buy
- Analyst Count
- FUNC 0
- CDXS 2
- Target Price
- FUNC N/A
- CDXS $11.00
- AVG Volume (30 Days)
- FUNC 17.6K
- CDXS 1.1M
- Earning Date
- FUNC 04-22-2025
- CDXS 05-01-2025
- Dividend Yield
- FUNC 2.94%
- CDXS N/A
- EPS Growth
- FUNC 40.00
- CDXS N/A
- EPS
- FUNC 3.15
- CDXS N/A
- Revenue
- FUNC $76,870,000.00
- CDXS $59,345,000.00
- Revenue This Year
- FUNC $13.86
- CDXS $14.56
- Revenue Next Year
- FUNC $8.36
- CDXS $21.41
- P/E Ratio
- FUNC $9.77
- CDXS N/A
- Revenue Growth
- FUNC 10.26
- CDXS N/A
- 52 Week Low
- FUNC $19.17
- CDXS $2.43
- 52 Week High
- FUNC $42.50
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- FUNC 35.25
- CDXS 42.35
- Support Level
- FUNC $29.08
- CDXS $2.43
- Resistance Level
- FUNC $31.03
- CDXS $3.04
- Average True Range (ATR)
- FUNC 0.99
- CDXS 0.22
- MACD
- FUNC 0.06
- CDXS 0.08
- Stochastic Oscillator
- FUNC 21.63
- CDXS 51.35
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.